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Summary 
Experimental induction of most autoimmune diseases appears to depend on the activation of 
CD4 + T helper cells, while CD8 + lymphocytes may have a role in disease progression. To study 
the role of CD4 + and CD8 + T  cell subsets  in T  cell-dependent autoimmunity, mice lacking 
CD4 or CD8 molecules after gene targeting were injected with cardiac myosin to induce organ 
specific autoimmune myocarditis. Mice homozygous for the CD8 mutation (CD8-/-) developed 
significantly  more  severe  disease  as  compared  to  CD4+/-CD8 +/-  controls.  Surprisingly, 
CD4-/-  mice developed autoimmune myocarditis with infiltration of TCRceB+CD4-CD8- 
T  cells in the heart tissue and appearance of autoantibodies. These data demonstrate that the 
lack of CD4 + or CD8 + T  ceils has no significant influence on the initiation of autoimmune 
myocarditis. CD4 § and CD8 + cells regulate disease severity and these results may explain the 
occurrence of autoimmunity in CD4 immunodeficiencies. 
I 
n mice, autoimmune diseases arise either spontaneously or 
can be experimentally induced by injection of the specific 
autoantigen. Experimental induction of most autoimmune 
disease requires CD4 + T  helper lymphocytes responsive to 
the self-antigen presented on major histocompatibility com- 
plex (MHC) class II molecules (reviewed in reference 1). In 
virtually all experimental and genetic animal models of au- 
toimmunity, administration ofmonoclonal antibodies (mAb) 
against CD4 molecules blocks disease (reviewed in references 
2-5).  Thus, CD4 + T  helper cells are postulated to be cru- 
cial for the initiation and development of T  cell dependent 
autoimmunity and clinical trials targeting the CD4 + cell lin- 
eage to treat various human autoimmune diseases are cur- 
rently underway (2-5). Besides CD4 + cells, MHC class I re- 
stricted CD8 + lymphocytes can be found in autoimmune 
lesions (1-5). The significance and role of CD8 + lympho- 
cytes in the development of autoimmunity, especially in ex- 
perimentally induced autoimmune diseases, is controversial. 
Coxsackie virus (CB3)-induced myocarditis and dilated car- 
diomyopathy are the most frequent cardiac complications in 
young patients, and several clinical and experimental studies 
suggest that later stages of this disease are mediated by an 
autoimmune response (6-8). The human disease can be mim- 
icked in mice by inoculation of CB3-virus,  which in the mouse 
model probably leads to an autoimmune response to cardiac 
myosin exposed after virus-mediated myocyte  damage (9-11). 
This hypothesis is supported by the fact that myocarditis can 
be induced with purified cardiac myosin, i.e., in the absence 
of virus (12). Cardiac myosin-induced autoimmune myocar- 
ditis is strictly organ-specific and cannot be induced with other 
isoforms of muscle myosin (12). Experimental induction of 
autoimmune myocarditis is MHC class II haplotype depen- 
dent and can be inhibited by treatment with mAbs against 
MHC class H or CD4 molecules (13). Adoptive transfer studies 
in SCID mice have also demonstrated that autoantigen-induced 
myocarditis is mediated by CD4 + cells (14). By contrast, im- 
munodepletion studies  suggested that  CD8 +  cells  have a 
pathogenic role in later phases of the disease  (13). 
Mice rendered CD4 or CD8 deficient as a result of gene 
targeting  (15,  16)  are ideal  models  to  study  the role  of 
CD4 + and CD8 + T cell subsets in the development of au- 
toimmune  diseases.  To  investigate  whether  CD4 -/-, 
CD8-/-  or control CD4 +/- CD8 +/-  mice are susceptible 
to antigen-induced myocarditis, these mice were injected with 
purified cardiac myosin (12).  We show that both CD4-/- 
and CD8 -/-  mice develop autoimmune myocarditis sug- 
gesting that the initiation of antigen-induced autoimmunity 
does not depend on CD4 + or CD8 + T  cells. 
Materials  and Methods 
Mice.  To generate mice in an MHC haplotype susceptible to 
cardiac myosin-induced autoimmune disease, CD4 or CD8 gene 
deficient mice (15, 16)  were backcrossed into  a  B10.Br strain 
(H-2  k) (CD4 -/-  =  4  th backcross; CD8 -/-  =  5  `b backcross). As 
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female CD4-/-  (B10.Br; 4  ~h backcross) mice of the same breeding 
nucleus  to  generate  mice heterozygous at  both  loci  (CD4 +/- 
CD8+/-). It should be noted that CD4 -/- or CD8 -/- through- 
out the text refers to CD4-/-CD8 +/+ or CD4+/+CD8-/-  geno- 
types. Care of animals  was in accordance with guidelines of the 
Canadian Research Council. 
Immunization Procedure.  Cardiac myosin was purified from mice 
as described (17). 7-wk-old mice were immunized twice at a 7-d 
interval (subcutaneously) with 150/zg of cardiac myosin emulsified 
in Freund's complete adjuvant (FCA) or with FCA alone (12). 
21 d after the first immunization, mice were sacrificed and ana- 
lyzed histologically for infiltration of the heart muscle and sero- 
logically for the presence of IgG auto-Abs against  cardiac myosin 
(10, 12). For histological analysis, hearts were fixed in formalde- 
hyde and processed for hematoxylin and eosin staining.  IgG auto- 
Ab titers were determined by ELISA-technique using the cardiac 
myosin isoform as test antigen (12, 17). Specificity of myosin IgG 
auto-Abs against the cardiac isoform has been demonstrated previ- 
ously (17). 
Immunoc),tometr),.  For immunoperoxidase staining (13), cryostat 
sections were fixed in acetone (10 min) and endogenous peroxidase 
reactivity blocked with NaN3  and H202. After incubation with 
mAbs (30 rain), sections were washed in tris-buffered saline (TBS, 
pH 7.4) and further incubated with peroxidase-conjugated rabbit 
anti-rat Ig (0.25 mg/ml; DAKOPATTS, Copenhagen, Denmark) 
or unconjugated rabbit anti-hamster IgG (0.1 mg/ml; Jackson Im- 
munoResearch Laboratories, Inc., West Grove, PA) followed by per- 
oxidase  conjugated  swine  anti-rabbit  Ig  (0.25  mg/ml; 
DAKOPATIS). All sections were developed for 10 min with 0.06% 
diaminobenzidine and 0.01% H202 and counter-stained with he- 
matoxylin. 
The following mAbs were used: Mac-1 (rat IgG2b; done M1/70); 
GK1.5  (anti-CD4;  rat  IgG2b);  53-6.72  (anti-CD8cULyt2;  rat 
IgG2a); KT3 (anti-CD3; rat IgG); GD3 (anti-pan TCR-'y#; ham- 
ster IgG); H57-597.2.1  (anti-pan TCKotfl; hamster IgG). All mAbs 
were derived from American Type Culture Center, Rockvilh, MD) 
and used as supernatants. 
Results and Discussion 
CD4 -/-,  CD8 -/-,  or  control  CD4+/-CD8 +/-  mice 
were injected with purified cardiac myosin in FCA (12). In 
comparison to CD4 +/- CD8 + / -  mice, CD8 -/-  animals de- 
veloped a significantly more severe disease as assessed by the 
histological extent of heart infiltration (Table 1 and Fig.  1, 
a and b) suggesting that CD8 + lymphocytes do not only act 
as cytotoxic effector cells in autoimmunity but may also regu- 
late the severity of disease (18). A  similar regulatory role of 
CD8 + T  cells has been previously described in experimental 
autoimmune encephalitis (EAE), i.e., increased frequency of 
relapses in CD8-/-  mice and resistance to a second induc- 
tion of EAE in mice depleted of CD8 + cell using mAbs (19, 
20). More surprisingly,  CD4-/-  animals injected with the 
autoantigen also developed autoimmune myocarditis (Fig. 1 
Table  1.  Incidence and Histological Severity of Cardiac 
Myosin-induced Myocarditis in CD4 -/-,  CD8 -/-,  and 
CIM+/-CD8+/-  Mice 
Genotype  Immunization 
Myocarditis 
Incidence  Severity 
(positive animals/  in positive 
total)  animals 
CD4+/-8+/-  Cardiac myosin  5/12  1.8  _+ 0.8 
CD4+/-8§  FAC only  0/6  - 
CD4 -/-  Cardiac myosin  3/6  1.0  _+ 0.0 
CD4 -/-  FCA  0/7  - 
CD8 -/-  Cardiac myosin  4/5  3.3  _+  1.0 
CD8 -/-  FCA  0.8  - 
Incidence and disease severity were scored histologically on hematoxin 
and eosin stained heart sections in a double blind test by two indepen- 
dent investigators. Histological grading of severity is (12, 17): 0  I  no 
infiltration  in heart muscle; 1 ~ up to 5% of histological  section  is infiltrat- 
ed; 2 ~  5-10%; 3 ~  10-20%; 4 ~  >20%. Disease severity was com- 
pared between different groups injected with cardiac myosin using a 
Student's t test: CD4+/-CD8 §  vs. CD4 -/- , no significant difference 
(p >0.05);  CD4*/-CD8 */-  vs. CD8 -/-  and CD4-/-vs.  CD8 -/-, 
significantly different  (p  <0.05).  The  incidence of disease in  both 
CD4 -/-  and  CD8 -/-  animals  did  not  differ  significantly from 
CD4+/-CDS+/-  controls (~2-test, p )0.05). One representative  experi- 
ment is shown. The results were confirmed  in two additional  experiments. 
c).  Incidence  and  severity of autoimmune  myocarditis  in 
CD4-/-  mice were comparable to CD4 +/- CD8 +/-  con- 
trol mice (Table 1). 
Table 2  summarizes  immunoperoxidase  staining  of cells 
infiltrating the heart tissue of animals that had developed au- 
toimmune disease. In all mice analyzed, the cellular infiltrate 
was  composed  of  macrophages  (Mac-1 +,  70--80%)  and 
CD3 + T  lymphocytes (16-24%).  In CD4+/-CD8 +/- con- 
trol  mice  almost  all  (>95%)  infiltrating  T  cells  were 
TCRc~fl + and expressed either CD4 or CD8 accessory mol- 
ecules.  The same results  have been previously obtained in 
normal B10.Br and other mouse strains (data not shown and 
reference  13).  In  CD8 -/-  mice,  virtually  all  infiltrating 
TCRc~fl + cells coexpressed CD4  molecules.  Strikingly,  in 
CD4-/-  mice <30% of TCRoefl + lymphocytes infiltrating 
the heart expressed CD8  molecules. These data show that 
most TCRolfl + lymphocytes present in autoimmune lesions 
of CD4-/-  mice have a CD4- CD8-  phenotype. TCR3,/~ + 
cells could be found in hearts of CD4 +/- CD8 +/-, CD8-/-, 
and  CD4-/-  mice in a  low frequency (Table 2). 
The  antibody  response  to  a  T  cell-dependent  antigen, 
Figure  1.  Cellular  infiltrates in hearts of CD4§  +/- (a), CD8-/-  (b), and CD4 -/- mice (c) injected with cardiac myosin. In all cases, the 
infiltrates of mononuclear cells are diffuse and interstitial. (d) shows the normal morphology of heart muscle from a CD4 -/- mouse injected with 
FCA alone. It should be noted that heart areas are shown to illustrate infiltration and that the infiltrations shown to not correspond to histological 
grading of the whole heart as described in Table 1. Hearts were taken from mice 21 d after first injection of cardiac myosin (12), fixed in formaldehyde, 
and processed for conventional histology (hematoxin and eosin staining),  x80. 
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CD4*/-CD8*/-,  CD4 -/-,  and CD8 -/-  Mice 
Phenotype  CD4 +/- CD8 +/-  CD4-/-  CD8-/- 
Mac-1  78.4  74.3  69.6 
CD3  16.1  17.7  23.7 
TCRr~B  16.2  14.1  20.1 
TCIL.y~  1.3  3.0  3.4 
CD4  8.2  0  20.9 
CD8  7.1  3.9  0 
Heart sections were stained with indicated mAbs followed by peroxidase 
labeled second stage Abs (13). In each instance, at least 1000-2500 infiltrat- 
ing cells were counted. Numbers indicate percentages of positive cells 
among  total infiltrating cells.  Percentages  are  shown  for one  animal 
representative of each haplotype. Phenotypes and percentages of infiltrating 
cells, expecially the prevalence of CD4-CDS-TCRc~B*  lymphocytes  in 
the heart infiltrate of CD4 -/-  mice, were confirmed in more animals 
(not shown). Unspecific background staining was in all instances <1% 
of infiltrating cells. 
SRBC, is markedly reduced in CD4 -/-  mice (15). Since 
mice with myocarditis develop high titers of IgG autoanti- 
bodies (auto-Ab) against cardiac myosin (10, 21, 22), we ana- 
lyzed  whether  auto-Abs  were  present  in  CD4 -/-  or 
CD8-/-  mice. Fig. 2 shows titers of anti-myosin IgG auto- 
Abs in mice injected with cardiac myosin or FCA alone. All 
CD4+/-CD8 +/-  and  CD8 -/-  mice with  cellular  heart 
infiltrate  developed high titers of IgG auto-Abs, and high 
auto-Ab titers correlated with the severity of cellular infiltra- 
tion. Surprisingly, experimental autoimmune myocarditis in 
CD4 -/-  animals was accompanied by the appearance of IgG 
auto-Abs (Fig.  2). Mice injected with FCA alone did not 
show any heart infiltration (Table 1 and Fig.  1 d) or high 
titers of auto-Abs (Fig.  2). 
Development of specific IgG auto-Abs against cardiac my- 
osin in the absence of help by CD4 + T  cells suggests that 
cells other than CD4 + lymphocytes are functional that can 
induce immunoglobulin-class switching and myosin specific 
IgG auto-Ab production. Alternatively, IgG auto-Ab produc- 
tion in myocarditis may not require T cell help. Since, how- 
ever, experimental autoimmune myocarditis is T cell depen- 
dent (13, 14) and auto-Ab titers are abrogated after treatment 
with anti-CD4 and anti-MHC class II mAbs (14), the pro- 
duction of IgG auto-Abs appears  to depend on T  helper 
cells. Few examples of autoimmunity have been described that 
may be mediated by CD4-CD8-TCRcr3 + (23) or CD4- 
CD8-TCIL~//~ + cells (24)  and vast  numbers CD4-CD8- 
TCRc~ + lymphocytes arise in autoimmune gld/gld or Ipr/ 
Ipr mice (reviewed in 25). Approximately 10% of peripheral 
T  cells in  CD4 -/-  mice  have  a  CD4-CD8-TCILolB + 
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Figure 2.  Myosin  IgG  autoantibody  titers  in  CD4*/-CD8 +/-, 
CD8-/-,  and CD4-/-  mice injected with cardiac myosin in FCA or 
with FCA alone. (Filled circles) Individual mice with myocarditis. (Open 
circles) Mice without disease. Sera were collected from mice 21 d after ini- 
tial cardiac myosin injection and myosin IgG auto-Ab titers were deter- 
mined by ELISA-technique  (17). 
phenotype (15) and it has been demonstrated that these cells 
can provide MHC class II restricted  help for T  cell depen- 
dent antibody production (Rahemtulla, A., T. M. Kuendig, 
A.  Narendran, M.  F. Bachmann, M. Julius, P. S. Ohashi, 
C. J. Paige, R. M. Zinkernagel,  and T. W. Mak; manuscript 
submitted for publication).  It should be noted that CD4- 
CDS-TCILol~ + T  cells in CD4 -/-  mice display a pheno- 
type previously described for various normal mouse strains 
(26-29) suggesting that these cells constitute a T cell popula- 
tion that is also present in normal mice but that is expanded 
in CD4-/-  mice. 
Our data demonstrate that T  cell-dependent and organ- 
specific autoimmune diseases, i.e., autoimmune myocarditis, 
can develop in mice lacking CD4* or CD8 + T cells. Both 
T cell subsets, however, participate in disease propagation in 
which CD4-/-  mice develop a mild, but CD8-/-  mice a 
more severe form of disease. In CD4-/-  mice, most T cells 
infiltrating the heart muscle have a TCRol~+CD4-CD8 - 
phenotype, a cell population is probably also responsible for 
initiation of autoimmunity in these mice. The same popula- 
tion is probably also responsible for the development of EAE 
in CD4-/-  mice (Koh, D. R., A. Ho, A. Rahemtulla, and 
T. K. Mak, manuscript submitted for publication). These 
data caution against attempted treatments of autoimmune 
diseases with mAbs against CD4 or CD8 molecules (2-5) 
since other than CD4 + or CD8 +, cell populations have the 
functional capability to induce organ-specific autoimmunity 
and might explain the occurrence of autoimmunity in pa- 
tients with genetic or acquired immunodeficiency  syndromes, 
e.g., the high incidence of non-viral myocarditis in AIDS pa- 
tients (30). 
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